位置:首页 > 产品库 > 重组次要组织相容性复合体HA1(HMHA1)蛋白
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组次要组织相容性复合体HA1(HMHA1)蛋白
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

重组次要组织相容性抗原HA 1蛋白
Recombinant ARHGAP45
基因名:

ARHGAP45


产品别名:

HA-1; HLA-HA1; HMHA1; ARHGAP45; Rho GTPase activating protein 45; Rho GTPase activating protein 45; rho GTPase-activating protein 45; histocompatibility (minor) HA-1; minor histocompatibility antigen HA-1; minor histocompatibility protein HA-1; 次要组织相容性复合体HA1(HMHA1); 次要组织相容性抗原HA 1;


背景信息:
Major histocompatibility complex (MHC) molecules, which include human leukocyte antigens (HLAs), form an integral part of the immune response system. They are cell-surface receptors that bind foreign peptides and present them to cytotoxic T lymphocytes (CTLs). Minor histocompatibility antigens can form an immune response upon recognition by certain T-cells when complexed with MHC molecules. HA-1 (minor histocompatibility protein HA-1), also known as HA-1, HLA-HA1 or HMHA1, is a 1,136 amino acid GTPase activator of Rho-type GTPases. Expressed in dendritic cells, epidermal Langerhans cells, hematopoietic cells, peripheral blood mononuclear cells and all leukemia and lymphoma cell lines, HA-1 is also found in various solid tissues and tumors. Highly phosphorylated, HA-1 contains one Rho-GAP domain, a single phorbol-ester/DAG-type zinc finger and is encoded by a gene located on human chromosome 19p13.3.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025